374 related articles for article (PubMed ID: 19261838)
1. Testosterone patches for female sexual dysfunction.
Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
[TBL] [Abstract][Full Text] [Related]
3. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
4. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
6. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
[TBL] [Abstract][Full Text] [Related]
8. Role of testosterone in the treatment of hypoactive sexual desire disorder.
Schwenkhagen A; Studd J
Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
[TBL] [Abstract][Full Text] [Related]
9. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
10. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
[TBL] [Abstract][Full Text] [Related]
12. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
Schover LR
Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.
Nachtigall L; Casson P; Lucas J; Schofield V; Melson C; Simon JA
Gynecol Endocrinol; 2011 Jan; 27(1):39-48. PubMed ID: 21142609
[TBL] [Abstract][Full Text] [Related]
14. Hypoactive Sexual Desire Disorder and current pharmacotherapeutic options in women.
Palacios S
Womens Health (Lond); 2011 Jan; 7(1):95-107. PubMed ID: 21175394
[TBL] [Abstract][Full Text] [Related]
15. Testosterone patch: new drug. Don't use to stimulate women's sexual desire.
Prescrire Int; 2007 Oct; 16(91):190-2. PubMed ID: 17926827
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
El-Hage G; Eden JA; Manga RZ
Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
[TBL] [Abstract][Full Text] [Related]
17. Testosterone supplementation for hypoactive sexual desire disorder in women.
Woodis CB; McLendon AN; Muzyk AJ
Pharmacotherapy; 2012 Jan; 32(1):38-53. PubMed ID: 22392827
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy for sexual dysfunction in postmenopausal women.
Hubayter Z; Simon JA
Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
[TBL] [Abstract][Full Text] [Related]
19. Goldilocks and menopause.
Vigersky RA
Arch Intern Med; 2005 Jul; 165(14):1571-2. PubMed ID: 16043673
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Davis SR; Braunstein GD
J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]